Brief: Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini
June 26 (Reuters) - Biomerieux SA BIOX.PA :
* RECEIVES U.S. FDA SPECIAL 510(K) CLEARANCE AND CLIA-WAIVER
FOR
ITS BIOFIRE® SPOTFIRE® RESPIRATORY/SORE THROAT (R/ST) PANEL MINI
* THE NEW BIOFIRE SPOTFIRE R/ST PANEL MINI WILL BE AVAILABLE
IN
THE THIRD QUARTER OF 2024 IN THE UNITED STATES
* IT IS INTENDED TO BE COMMERCIALIZED TOGETHER WITH THE
LARGER
MULTIPLEX BIOFIRE SPOTFIRE R/ST PANEL
Source text for Eikon: ID:nNDL40N0NX
Further company coverage: BIOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biomerieux SA
See all newsFactbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development